Dr Anthony Dalby brings the ACC 2020 virtual conference to you. With topics on risk factor management, acute and chronic coronary syndromes, stable cardiovascular disease and cardiomyopathy and heart failure, and more.
American College of Cardiology Congress update 2020
Printable Q&A for Offline SubmissionQuiz-summary
0 of 10 questions completed
Questions:
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
Information
You have already completed the module before. Hence you can not start it again.
Module is loading…
You have to finish following quiz, to start this quiz:
Results
Results
Time has elapsed
Categories
- Not categorized 0%
-
Thank you, we will review your submission and notify you of your results via email.
If not received within 5 hours due to spam, don’t worry, it will show in your profile.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- Answered
- Review
- Question 1 of 10
1. Question
1. In the renal denervation trial of hypertensive patients not on medicine, what level of blood pressure reduction was achieved in the denervation group?
- Question 2 of 10
2. Question
2. What percentage of patients in the renal denervation group had to be treated for BP>180mmHg?
- Question 3 of 10
3. Question
3. Wits University research in homozygous familial hypercholesterolaemia patients on high intensity statin, a PCSK-9 inhibitor and ezetimibe achieved a further reduction with evinacumab of:
- Question 4 of 10
4. Question
4. In the Ischemia-CKD study of patients with chronic coronary syndrome and kidney injury, the invasive group undergoing cardiac catheterisation had_______in respect of the stage of chronic kidney disease as those in the medically treated group.
- Question 5 of 10
5. Question
5. Rivaroxaban and aspirin in the COMPASS trial of diabetic patients with stable coronary/peripheral disease resulted in a MACE reduction of what percent compared to aspirin along?
- Question 6 of 10
6. Question
6. In the TICO study using ultrathin bioresorbable sirolimus-eluting stents, 3 months treatment post-PCI with aspirin and ticagrelor followed by ticagrelor alone till 12 months had lower bleeding rates than 12 months of aspirin plus ticagrelor.
- Question 7 of 10
7. Question
7. The use of colchicine post MI in the COLCOT trial was shown to reduce costs by what percent over the trial period:
- Question 8 of 10
8. Question
8. The DAPPA-HF trial in patients with heart failure and educed ejection fraction treated with dapagliflozin showed an absolute reduction of CV death and hospitalisation for heart failure of:
- Question 9 of 10
9. Question
9. A number of clinical trials now support the use of anticoagulation with P2Y12 monotherapy in patients with AF following acute coronary syndrome or PCI intervention.
- Question 10 of 10
10. Question
10. TAVR in a real-world study in the UK in older patients with severe artic stenosis resulted in a what death rate compared to conventional surgery?
Do you like this? Share with a colleague
[DISPLAY_ULTIMATE_SOCIAL_ICONS]